Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Charite University, Berlin, Germany
TSO has an impact on the Th1-Th2 balance and effects Il-10 producing B-cells, mechanisms that result in an antiinflammatory effect.
A 12 month treatmet with TSO is safe and well-tolerated
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
active Recurrent remittent Multiple Scleosis or Clinically isolated Syndrome
inefficacy or intolerance for a therapy with Interferon-beta
age 18 - 65
EDSS \<4
You may not be if
secondary or primary chronic progressive Multiple Sclerosis
Immunomodulatoric or immunosuppressive therapy
Clareo Health | Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome
